Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF (SHIELD-RSV)

NCT07693166 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT07693166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07693166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF (SHIELD-RSV)
Lead sponsor
University of British Columbia
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
March 1, 2028
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, rsv immunization